Bactericidal activity of curcumin I is associated with damaging of bacterial membrane.
Tyagi P, Singh M, Kumari H, Kumari A, Mukhopadhyay K. · 2015
Read Bactericidal activity of curcumin I is associated with damaging of bacterial membrane. by Tyagi P, Singh M, Kumari H, Kumari A, Mukhopadhyay K. (2015) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4374920.txt.
Introduction
Poonam Tyagi and co-authors tested how curcumin, the yellow compound in turmeric, kills bacteria, in PLoS ONE in 2015. Curcumin I, a main part of store-bought curcumin, is known for antioxidant effects, but its antibacterial action was less clear. The team exposed four disease-causing bacteria, two Gram-positive and two Gram-negative, to curcumin I and checked what broke inside the cells.
Curcumin I killed all four test species strongly, despite their different cell walls. Two dye tests that reveal leaky membranes both showed leakage after exposure. Electron and fluorescence microscope images confirmed visible membrane damage in the treated cells. The killing thus runs through membrane harm, a broad route that works across bacterial types. The authors suggest the finding could spur work on curcumin I against fast-spreading resistant pathogens.
Catalog record
| CREATOR | Tyagi P, Singh M, Kumari H, Kumari A, Mukhopadhyay K. |
|---|---|
| YEAR | 2015 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 40 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Bactericidal Activity of Curcumin I Is Associated with Damaging of Bacterial Membrane By Poonam Tyagi, Madhuri Singh, Himani Kumari, Anita Kumari, Kasturi Mukhopadhyay, Dongsheng Zhou Published in: PLoS ONE DOI: 10.1371/journal.pone.0121313 ABSTRACT Abstract Curcumin, an important constituent of turmeric, is known for various biological activities, primarily due to its antioxidant mechanism. The present study focused on the antibacterial activity of curcumin I, a significant component of commercial curcumin, against four genera of bacteria, including those that are Gram-positive (Staphylococcus aureus and Enterococcus faecalis) and Gram-negative (Escherichia coli and Pseudomonas aeruginosa). These represent prominent human pathogens, particularly in hospital settings. Our study shows the strong antibacterial potential of curcumin I against all the tested bacteria from Gram-positive as well as Gram-negative groups. The integrity of the bacterial membrane was checked using two differential permeabilization indicating fluorescent probes, namely, propidium iodide and calcein. Both the membrane permeabilization assays confirmed membrane leakage in Gram-negative and Gram-positive bacteria on exposure to curcumin I. In addition, scanning electron microscopy and fluorescence microscopy were employed to confirm the membrane damages in bacterial cells on exposure to curcumin I. The present study confirms the broad-spectrum antibacterial nature of curcumin I, and its membrane damaging property. Findings from this study could provide impetus for further research on curcumin I regarding its antibiotic potential against rapidly emerging bacterial pathogens. INTRODUCTION Curcumin is a natural component of the rhizome Curcuma longa, also known as turmeric. Since ancient times, the root of turmeric has been popular as a spice in India and other Asian countries. It is also commonly used for medicinal purposes, particularly to treat inflammatory conditions [1]. Over the years, curcumin has been explored for various clinical applications. Previous research has shown that it plays a therapeutic role in many diseases including diabetes, inflammatory disorders and different types of cancers [2–4]. Curcumin is a pleiotropic molecule that interacts with multiple targets involved in inflammatory reaction such as tumor necrosis factor-alpha (TNFα) and interleukins (ILs) [5]. Curcumin has also been shown to possess in vitro anti-microbial potential against a wide range of microorganisms including fungi [6] as well as several Gram-positive and Gram-negative bacteria [7–17]. Recently, Song et al. [9] showed that curcumin suppresses adherence of Streptococcus mutants to human tooth surfaces and extra-cellular matrix protein. Research has further highlighted that curcumin possesses a synergistic effect with important antibiotics such as cefixime, vancomycin and tetracycline against Staphylococcus aureus (S. aureus) [10–12]. However, very few studies have demonstrated the mechanism of antibacterial activity of curcumin I which seems to differ depending on the strain being studied. For instance, studies have demonstrated that the antibacterial activity of curcumin against Bacillus subtilis occurs through the inhibition of bacterial cell proliferation by blocking the assembly dynamics of FtsZ in the Z ring [15, 16]. In the case of Pseudomonas aeruginosa (P. aeruginosa) infection, curcumin was shown to have anti-infective activity through affecting virulence, quorum sensing and biofilm initiation [17]. Moreover, these mechanisms have not been confirmed in the case of other bacterial genera, hence could not be generalized for all bacteria. Therefore, a detailed study on antibacterial mechanism of curcumin, including a large number of bacteria from different genera is required. Due to the increase of resistance in Gram-positive and Gram-negative bacteria, there is an urgent need to identify and assess alternative antimicrobials, including those from plant materials with low human cytotoxicity. Curcumin I showed no toxic effect on human health even when taken at doses as high as 8 g day−1 [18, 2]. Considering these factors, in the present study, we investigated the detailed antibacterial activity of curcumin I (the major component of commercial curcumin) against two Gram-positive bacteria, namely, S. aureus and Enterococcus faecalis (E. faecalis), and two Gram-negative bacteria, namely, Escherichia coli (E. coli) and P. aeruginosa. We extended our study to explore the bacterial membrane lysis induced by curcumin I against the organisms from the mentioned bacterial groups. The membrane lysing properties of curcumin were further viewed through scanning electron microscopy and confocal fluorescence microscopy. MATERIALS AND METHODS Materials Curcumin I (purity ≥ 97%) and brain heart infusion (BHI) media were purchased from Himedia, India. Human neutrophil peptide-1 (HNP-1), nisin, gramicidin D, calcein-AM (solubilized in dimethyl sulfoxide (DMSO)) and propidium iodide (PI) were procured from Sigma-Aldrich, USA. Glutaraldehyde was ordered from Merck, Germany. The stock concentration of curcumin I was made in DMSO, and the working concentrations were diluted in PBS for killing assays in such a way that the DMSO concentration remains <1%. Microbial strains Two Gram-positive bacteria; S. aureus ATCC 29213 and E. faecalis ATCC 29212, and two Gram-negative bacteria; E. coli ATCC 25922 and P. aeruginosa ATCC 25619, were used in this study. These strains were stored at −80°C in 15% (v/v) glycerol until sub cultured onto BHI agar plate for further studies. Killing assay The killing assay was performed according to the procedure mentioned in our previous publications [19, 20]. Bacterial cells were grown in BHI broth to mid logarithmic phase. Using spectrophotometer, the optical density (OD 600nm) of cells was adjusted to 0.5 (~108 CFU/ml) in 10 mM PBS buffer (pH 7.4). A final inoculum of 106 and 104 CFU/ml was exposed to various concentrations of curcumin I (25 μM, 50 μM & 100 μM) in the presence of PBS [19]. At the chosen time points (30 min, 60 min & 120 min), aliquots were taken, placed on BHI agar plate in triplicates and incubated overnight at 37°C. Next day, the bacterial colonies were counted and bacterial survival was expressed as the mean percentage of survival versus non-peptide treated control (set as 100% survival). Each experiment was repeated independently on three separate days. Membrane permeabilization assay Permeabilization of the membrane of S. aureus and E. coli following exposure to curcumin I was determined, using both steady-state fluorescence and flow cytometry techniques. Two strategic assays were performed: (a) uptake of extracellular PI by permeabilized cells, and (b) leakage of preloaded calcein from the permeabilized cells. Propidium iodide (PI) uptake assay PI intercalates with bases of deoxyribonucleic acid (DNA) and gives fluorescence. PI can enter the bacterial cell membrane only when it has been permeabilized through an agent, and bind with DNA. This DNA-bound PI fluoresces with excitation and emission at 544 nm and 620 nm, respectively. The fluorescence emission can be detected by both spectrofluorimeter [19] and flow cytometer [21] equipped with an appropriate filter. Briefly, S. aureus and E. coli cells were grown in BHI broth up to the mid logarithmic phase, harvested, washed, and adjusted to 106 CFU/ml in PBS buffer. The cells were incubated at 37°C with curcumin I (25 μM, 50 μM & 100 μM) and simultaneously with two bacterial membrane permeabilizing agents HNP-1 and nisin (both have been used as positive controls) at indicated time points. After curcumin exposure, the cells were washed in PBS buffer and incubated with PI (1.3 μg/ml) at 37°C for 20 min in dark. The PI fluorescence was measured at excitation and emission of 544 nm and 620 nm respectively, through a fluorescence spectrophotometer (Shimadzu RF-5301 PC spectrofluorimeter, Japan). Similarly, separate aliquots were prepared and measured in the flow cytometer (Becton Dickinson (BD) Facs verse, San Jose, CA, and Beckman Coulter, CA). A total of 10,000